trial · primary record
TER-2013
Breast Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 248 |
| Primary completion | 2029-02-28 |
| Primary endpoint | Number of Patients who Experience Dose-Limiting Toxicity |
| Registry ID | NCT07109726 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:08.768Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07109726
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.